contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


pmd-device-solutions-announces-delay-to-q3-2024-quarterly-report

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Promore Pharma

[Cork, Ireland – 20th November 2024] – PMD Device Solutions (PMDS), a leader in digital healthcare solutions, announces a delay in the release of its Q3 2024 financial results. The updated release...

<div class="mfn-preamble"><p><strong>[Cork, Ireland – 20th November 2024] – PMD Device Solutions (PMDS), a leader in digital healthcare solutions, announces a delay in the release of its Q3 2024 financial results. The updated release date has been set for 29th November 2024.</strong></p></div><div class="mfn-body"><p>The delay is due to the ongoing consolidation of newly acquired companies, the administrative follow-up from the recent successful funding round, and the outcomes of the Extraordinary General Meeting (EGM). These events, following after the original proposed financial timetable, reflect the scale of transformational developments currently underway at PMDS to position the company for long-term growth.&nbsp;</p><p>&nbsp;Myles Murray, CEO of PMD Device Solutions, commented:&nbsp;<br>“While this delay in reporting is a departure from our scheduled financial calendar released in January of this year, it is solely driven by administrative aspects and underscores the complexity of the business transformation and proactive steps being taken to strengthen PMDS. We remain confident in meeting our 2024 financial targets and believe these initiatives will lay the foundation for a robust and sustainable future for the company.”</p></div><div class="mfn-footer mfn-contacts mfn-c00f131ce405"><p><strong class="mfn-heading-1">For additional information, please contact</strong></p><hr><p> Myles Murray, CEO<br>Phone: +353 86&nbsp;887 4994<br>E-mail: <a rel="noopener" href="mailto:myles@pmd-solutions.com">myles@pmd-solutions.com</a> &amp;amp; for general enquiries <a rel="noopener" href="mailto:investor.relations@pmd-solutions.com">investor.relations@pmd-solutions.com</a>&nbsp;<br>The Company’s Certified Adviser is Redeye.</p></div><div class="mfn-footer mfn-a9ff3c84caa3"><p><strong class="mfn-heading-1">Information about PMDS</strong></p><hr><p>PMD&nbsp;Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital acute monitoring sector and the remote monitoring homecare sector. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to support the detection of patient deterioration early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company’s knowledge, the world’s only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA cleared in the US. The company’s shares are listed on Nasdaq First North Growth Market (STO: PMDS).</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/e2cf169c-2240-4171-bae7-664f4d5db628/pmd-device-solutions-announces-delay-to-q3-2024-quarterly-report-eng.pdf" class="mfn-primary">PMD Device Solutions Announces Delay To Q3 2024 Quarterly Report[ENG]</a></p></div>